Results of ANDANTE, a randomised clinical study with an anti-IL6 antibody (PF-04236921) in subjects with Crohn's disease who are antitumour necrosis factor inadequate responders

Danese, S., Vermeire, S., Hellstern, P., Panaccione, R., Rogler, G., Fraser, G., Kohn, A., Desreumaux, P., Leong, R. W., Comer, G. M., Cataldi, F., Banerjee, A., Maguire, M. K., Li, C., Rath, N., Beebe, J. and Schreiber, Stefan (2016) Results of ANDANTE, a randomised clinical study with an anti-IL6 antibody (PF-04236921) in subjects with Crohn's disease who are antitumour necrosis factor inadequate responders Journal of Crohns & Colitis, 10 . S12-S13.

Full text not available from this repository.

Document Type: Article
Additional Information: Times Cited: 0 Danese, S. Vermeire, S. Hellstern, P. Panaccione, R. Rogler, G. Fraser, G. Kohn, A. Desreumaux, P. Leong, R. W. Comer, G. M. Cataldi, F. Banerjee, A. Maguire, M. K. Li, C. Rath, N. Beebe, J. Schreiber, S. 1
Research affiliation: OceanRep > The Future Ocean - Cluster of Excellence
Kiel University
Refereed: Yes
ISSN: 1873-9946
Projects: Future Ocean
Date Deposited: 16 Mar 2017 07:47
Last Modified: 19 Dec 2017 12:47
URI: http://eprints.uni-kiel.de/id/eprint/36045

Actions (login required)

View Item View Item